PharmaShots | Incisive News in 3 Shots

Subscribe Now

elix pharmaceuticals

Telix Pharmaceuticals Reports the First Patient Dosing in P-III (ZIRCON-CP) Trial of TLX250-CDx for Kidney Cancer Imaging in China

Telix Pharmaceuticals Reports the First Patient Dosing in P-III (ZIRCON-CP) Trial of TLX250-CDx for Kidney Cancer Imaging in China

November 28, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us